These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4757768)

  • 1. [Reducing therapy in obesity].
    Dekant A; Dekant H
    Z Allgemeinmed; 1973 Sep; 49(27):1305-9. PubMed ID: 4757768
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolonged-action fenfluramine in non-diabetic patients with refractory obesity.
    Galloway DB; Logie AW; Petrie JC
    Postgrad Med J; 1975; 51 Suppl 1():155-7. PubMed ID: 768957
    [No Abstract]   [Full Text] [Related]  

  • 3. Fenfluramine and methylcellulose in the treatment of obesity: the relationship between plasma drug concentrations and therapeutic efficacy.
    Hossain M; Campbell DB
    Postgrad Med J; 1975; 51 Suppl 1(593):178-82. PubMed ID: 768965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of fenfluramine (with ad libitum food intake) with 1,000 calorie diet in obesity.
    Hooper AC
    J Ir Med Assoc; 1972 Jan; 65(2):35-7. PubMed ID: 5058787
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influence of fenfluramine on the weekly curve of weight loss during obesity].
    Cabezas Cerrato J; Gómez Pérez M; Marco-Mur AL; Camarero E; Fernández-Cruz A
    Rev Clin Esp; 1974 Jan; 132(1):47-52. PubMed ID: 4840227
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects and indications of fenfluramine in the treatment of obesity].
    Vignati E
    Vie Med Can Fr; 1973; 2(2):166-70. PubMed ID: 4706701
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical trial of a new long-acting fenfluramine in the treatment of obesity].
    Pugnoli C; Bandini L; Caronna S; Ciarlini E; Magnati G; Strata A; Tirelli F
    G Clin Med; 1978 Nov; 59(11):486-510. PubMed ID: 369930
    [No Abstract]   [Full Text] [Related]  

  • 8. Relative unresponsiveness of obese diabetic compared to obese non-diabetic subjects to the weight-reducing effect of fenfluramine.
    Otim MA
    East Afr Med J; 1977 Feb; 54(2):91-5. PubMed ID: 885093
    [No Abstract]   [Full Text] [Related]  

  • 9. The anorectic and hypotensive effect of fenfluramine in obesity.
    Hudson KD
    J R Coll Gen Pract; 1977 Aug; 27(181):497-501. PubMed ID: 616838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fenfluramine in the treatment of obesity.
    Spence AW; Medvei VC
    Br J Clin Pract; 1966 Dec; 20(12):643-4. PubMed ID: 5974503
    [No Abstract]   [Full Text] [Related]  

  • 11. A double-blind clinical trial of fenfluramine in the treatment of obesity.
    Sainani GS; Fulambarkar AM; Khurana BK
    Br J Clin Pract; 1973 Apr; 27(4):136-8. PubMed ID: 4586636
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fenfluramine in the treatment of obesity].
    Sedgwick JP
    Vie Med Can Fr; 1973 Mar; 2(3):243-7. PubMed ID: 4707493
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolonged action fenfluramine capsules versus fenfluramine tablets in general practice.
    Maneksha S
    Br J Clin Pract; 1975 Jan; 29(1):12-13. PubMed ID: 1095042
    [No Abstract]   [Full Text] [Related]  

  • 14. Fenfluramine in the management of obesity.
    Datey KK; Kelkar PN; Pandya RS
    Br J Clin Pract; 1973 Oct; 27(10):373-5. PubMed ID: 4601613
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experience with the appetite depressant, fenfluramine hydrochloride, in adiposity].
    Liebermeister H; Probst G; Jahnke K
    Med Klin; 1969; 64(26):1201-7. PubMed ID: 5807324
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical study of the use of a "false food" associated with an anorectic drug in the treatment of exogenous obesity].
    Manieri C; Biffignandi P; Molinatti GM
    Minerva Dietol Gastroenterol; 1979; 25(2):201-7. PubMed ID: 471302
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical trial of fenfluramine in the treatment of obesity in Thai people.
    Chandraprasert S; Israsena T
    Mod Med Asia; 1977 Dec; 13(12):10-2. PubMed ID: 604778
    [No Abstract]   [Full Text] [Related]  

  • 18. Double-blind cross-over study of fenfluramine (Ponderax) in obesity.
    Rastogi GK; Sharma PL; Saini GS; Kanen VL
    J Assoc Physicians India; 1972 Nov; 20(11):849-52. PubMed ID: 4570012
    [No Abstract]   [Full Text] [Related]  

  • 19. [Psychiatric complications in the treatment of obesity using fenfluramine].
    Klompenhouwer JL; Stricker BH; van Tilburg AJ; Moleman P; Pepplinkhuizen L
    Ned Tijdschr Geneeskd; 1988 Nov; 132(46):2114-7. PubMed ID: 3205320
    [No Abstract]   [Full Text] [Related]  

  • 20. [The therapeutic effect of Fenfluramine on body weight in overweight patients. A controlled clinical study].
    Haug E; Myklebust R
    Tidsskr Nor Laegeforen; 1973 Dec; 93(35):2545-9. PubMed ID: 4589598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.